News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AEterna Zentaris (AEZS) to Present at Upcoming Canaccord Genuity Global Growth Conference in Boston



8/7/2013 6:54:05 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

QUÉBEC CITY, Aug. 7, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the Company's Senior Vice President and CFO, Dennis Turpin, CPA, CA, will be presenting a corporate overview at the Canaccord Genuity 33rd Annual Global Growth Conference on Wednesday, August 14, 2013, at 11:00 am (Eastern), in the Paris Room of the Intercontinental Boston Hotel.

A live audio webcast of this presentation will be available on Aeterna Zentaris' website at www.aezsinc.com in the Newsroom section. A replay of the webcast will also be available on the Company's website for a period of 90 days.

About Aeterna Zentaris

Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. The Company's pipeline encompasses compounds from drug discovery to regulatory approval. For more information, visit www.aezsinc.com.

SOURCE Aeterna Zentaris Inc.



Hey, check out all the research scientist jobs. Post your resume today!

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES